Testing effectiveness (Phase 2)Active Not RecruitingNCT03934567
What this trial is testing
A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
Who this might be right for
Lymphoma, Follicular
Xynomic Pharmaceuticals, Inc. 87